✦ LIBER ✦
EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
✍ Scribed by Moerman, R. V.; Arends, S.; Meiners, P. M.; Brouwer, E.; Spijkervet, F. K. L.; Kroese, F. G. M.; Vissink, A.; Bootsma, H.
- Book ID
- 127029347
- Publisher
- BMJ Publishing Group
- Year
- 2013
- Tongue
- English
- Weight
- 140 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0003-4967
No coin nor oath required. For personal study only.